Blueprint Medicines Corp (DELISTED) (BPMC:DL)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Jul 28, 16:00
Blueprint Medicines Profit Margin (Quarterly): 0.33% for March 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| TG Therapeutics, Inc. | -- |
| AVITA Medical, Inc. | -77.29% |
| Ardelyx, Inc. | -0.88% |
| Bristol Myers Squibb Co. | 17.96% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.13% |
| Return on Assets | -13.39% |
| Return on Invested Capital | -23.09% |
| Gross Profit Margin (Quarterly) | 98.12% |
| Operating Margin (Quarterly) | -27.50% |
| Return on Net Operating Assets | -79.61% |